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Abstract
When malaria parasites infect host red blood cells (RBC) and proteolyze hemoglobin, a unique, albeit poorly understood
parasite-specific mechanism, detoxifies released heme into hemozoin (Hz). Here, we report the identification and
characterization of a novel Plasmodium Heme Detoxification Protein (HDP) that is extremely potent in converting heme into
Hz. HDP is functionally conserved across Plasmodium genus and its gene locus could not be disrupted. Once expressed, the
parasite utilizes a circuitous ‘‘Outbound–Inbound’’ trafficking route by initially secreting HDP into the cytosol of infected
RBC. A subsequent endocytosis of host cytosol (and hemoglobin) delivers HDP to the food vacuole (FV), the site of Hz
formation. As Hz formation is critical for survival, involvement of HDP in this process suggests that it could be a malaria drug
target.
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Introduction
Malaria is the most lethal parasitic disease and a dominant
public health issue in more than 100 nations. While malaria
infection begins with the invasion of hepatocytes by the
Plasmodium sporozoites inoculated by an infected mosquito, the
common clinical symptoms of malaria, which includes high
fever, chills and anemia, are due to the subsequent infection and
rapid multiplication of the parasite inside the RBC. To sustain
its rapid pace of development, the parasite digests host
hemoglobin, which represents 90% of the total protein present
inside an RBC [1]; approximately 75% of which is degraded
during the erythrocytic stages of development [2]. While
hydrolysis of hemoglobin makes amino acids available for
parasite development, this process also releases its lipophilic
prosthetic group–heme, which is extremely toxic to the parasite.
Therefore, along with a continuous degradation of hemoglobin,
a concomitant detoxification of heme is necessary for an
uninterrupted growth and proliferation of the parasite. Parasite
effectively detoxifies heme, primarily by its conversion into an
insoluble crystalline material called Hz. It is estimated that up to
75% of the free heme is processed into Hz [3,4]. In its human
host, heme detoxification is one of the homeostasis processes,
performed by a combination of proteins like hemopexin and
heme oxygenase [5], whose homologs have not been found in
the parasite genome.
Disruption of Hz formation is the most widely used strategy for
controlling malaria (Reviewed in [6]). For example, chloroquine
primarily acts by binding to free heme with 1:2 stoichiometry,
which prevents its detoxification into Hz [7,8]. Similarly, one of
the antimalarial activities of artemisinin involves its interaction
with heme, leading to the formation of heme adducts that cannot
be detoxified [9]. While the parasite-specific nature of this process
has led to the development of several more drugs that interact with
heme (i.e. the substrate), due to an incomplete knowledge of
parasite factors involved, antimalarials that can target the process
itself, have not been developed. The underlying mechanism,
though poorly understood, is believed to be highly conserved as
Hz formation occurs in all the species of Plasmodium during their
intraerythrocytic development, irrespective of the host species they
infect.
To date, parasite factors responsible for Hz formation are a
subject of intense debate. In vitro, a protein [10] and a lipid-driven
[11,12] processes for Hz synthesis have been described by several
research groups. Additionally, an autocatalytic process, where
preformed Hz promotes the conversion of free heme into Hz, has
also been proposed [13]. While it’s been argued that the currently
known parasite factors are not the major force behind the Hz
production activities of Plasmodium [14–16], others believe that
lipids could be the primary mediator of Hz formation in the
parasite [17,18]. Here we describe HDP, a parasite protein, which
is a potent producer of Hz and demonstrate that it reaches its
PLoS Pathogens | www.plospathogens.org 1 April 2008 | Volume 4 | Issue 4 | e1000053intracellular destination utilizing a novel trafficking route that has
not been seen for any of the known malaria proteins.
Results
Cloning, recombinant expression and purification of P.
falciparum HDP
P. falciparum HDP is a single copy, three-exons encoded [19],
205 amino acids long polypeptide (PlasmoDB # PF14_0446;
GenBank Acc# NP_702335; Fig. S1,S2). In P. falciparum parasites,
we found that the HDP gene was actively transcribed during the
intraerythrocytic stages of the lifecycle (Fig. S1A). To study its role
in the lifecycle of the parasite, the coding sequence of HDP was
cloned and expressed in E. coli. On expression, the recombinant
protein was localized in the inclusion bodies from which it was
purified to homogeneity, by a two-step column chromatography
(Fig. S1C,D).
HDP binds heme and converts it into Hemozoin
Purified HDP was utilized for investigating HDP-heme
interactions. First, we measured the affinity of HDP towards
heme by isothermal titration calorimetry (Fig. 1A). The analysis
revealed that HDP binds heme with high affinity (Kd=80 nM),
and possesses 2.7 heme binding sites. Having established its ability
to interact with heme, we evaluated HDP’s potential to convert
heme into Hz. In a Hz-production assay [10], where HDP was
present in enzyme-like concentrations (0.5 mM) and heme at
several hundred fold molar excess (300 and 600 mM), the protein
rapidly converted up to 50% of heme into hemozoin, in a
concentration dependent manner (Fig. 1B). HDP acted rapidly,
generating most of the Hz within the first 20 minutes. The
reaction achieved completion, typically within the first hour,
showing little change in Hz levels over longer incubation periods
(Fig. 1B). At the highest concentration of heme (600 mM) tested,
HDP converted 261 mM of heme into Hz, leading to a conversion
rate of 783 mM/hr/0.5 mM of protein. This translates into 1566
molecules of heme sequestered into Hz per hour/molecule of
HDP (Fig. 1B). To explore if the activity of the recombinant HDP
represents the function of the wild-type protein, we immunopre-
cipitated native HDP from the extracts of P. falciparum–infected
RBCs. Protein-specific antibodies were raised using the recombi-
nant HDP as an immunogen. The native protein was purified by
immunoprecipitation from the infected RBC extracts (Fig. S7B)
and though being a dimer, was found to be active, producing Hz
at levels comparable to the recombinant protein (Fig. 1C), thus
suggesting that in-vivo, HDP could indeed be involved in Hz
production. Purification of native HDP by immunoprecipitation
all but eliminated the possibility of lipids or HRP2 being present as
contaminants in the native HDP fraction isolated from the
parasite.
Authentication of HDP-produced crystalline material as
Hz
Parasite-produced Hz is identical to b-hematin and its unique
and well characterized powder X-Ray Diffraction (XRD) pattern
serves as its signature [3]. To authenticate that HDP-produced
crystalline material truly represents Hz, it was subjected to XRD
analysis. Diffraction pattern of HDP-produced crystallites was
dominated by an intense reflection at 7.35u 2h (Fig. 1D) and the
entire profile matched the pattern calculated from the previously
published profile of b-hematin [3]. This confirmed that the HDP-
produced substance crystallizes in the same unit cell and structure
as Hz. We also evaluated the size and morphology of HDP-
produced Hz crystals by scanning electron microscopy. HDP-
produced Hz was essentially constituted of randomly stacked
crystallites of 0.1–0.2 mm in length and approximately 0.05 mmi n
width (Fig. 1D-inset). Hz crystallites of similar dimensions are
found in parasite’s FV [8].
HDP is functionally conserved across Plasmodium genus
We identified HDP orthologs in seven other species of
Plasmodium [20,21] and its homologs in two species each of
Theileria [22] and Babesia [21] and in Toxoplasma gondii [23] genome
(Fig. S2). The protein showed 60% sequence identity within the
Plasmodium genus, but had considerable divergence outside, as the
overall sequence identity was less than 15%. We subsequently
evaluated if the function of HDP is conserved across Plasmodium
genus, by comparing the activities of HDP with its ortholog from
P. yoelii, a mouse malaria parasite. Coding sequence of P. yoelii
HDP (PyHDP) was amplified by RT-PCR, cloned, expressed in E.
coli and the protein was purified to homogeneity (data not shown).
PyHDP generated Hz at levels indistinguishable from its P.
falciparum ortholog (Fig. 1E), suggesting that the functionality of
HDP could indeed be conserved across Plasmodium genus.
Intact HDP is required for Hz production
The carboxyl terminus region (amino acids 88-205) of
Plasmodium HDP sequences have homology (e-value 3e-10) to
fasciclin-1, an ancient and highly diverse adhesive domain, present
in proteins of prokaryotic [24] and eukaryotic [25] origin (Fig. S2
and Fig. S1B). To check if this domain alone is responsible for the
Hz producing activities we prepared two truncated versions of
HDP (Fig. S1B). HDP3 encoded amino acids 88-205 of the full-
length protein, representing the fasciclin domain, while HDP2
encoded amino acids 1–87 and lacked the fasciclin domain (Fig.
S1B). The two constructs were expressed in E. coli and the purified
recombinant proteins (Fig. S1C,D) were evaluated for their
propensity to produce Hz (Fig. 1F). We found that both, HDP2
Author Summary
Each year, more than one million people, most of them
children under the age of 5, succumb to malaria, a
devastating disease caused by Plasmodium parasites. The
parasite resides inside the red blood cells of the host,
where, during its development, it proteolyzes vast
amounts of host hemoglobin. This degradation also
releases heme, which is extremely toxic to the parasite.
To protect itself (from the toxic effects of heme), the
parasite converts free heme into hemozoin. This parasite-
specific mechanism is widely accepted as the weakest link
in its lifecycle and is targeted by several of the currently
available antimalarial drugs, which prevent hemozoin
formation by binding to heme. However, due to an
incomplete understanding of the parasite processes that
lead to hemozoin formation, a drug that specifically
targets the parasite factors responsible for hemozoin
production has never been developed. Here we identify
and characterize Heme Detoxification Protein, a unique
Plasmodium protein, which we show as the potent
producer of hemozoin. We demonstrate that this protein
is highly conserved across the Plasmodium genus, is
extremely efficient in producing hemozoin, and is deliv-
ered to the food vacuole, the site of hemozoin formation,
via a unique trafficking route. We also demonstrate the
critical nature of this protein and suggest that it could be
targeted to develop novel antimalarial drugs.
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PLoS Pathogens | www.plospathogens.org 2 April 2008 | Volume 4 | Issue 4 | e1000053Figure 1. HDP rapidly detoxifies and sequesters heme as Hz. A, Heme (100 mM) solution was titrated into protein (5 mM) and the heat
evolved was measured by Isothermal titration calorimetry. Binding isotherm was generated by integrating the data from the top panel. B, HDP-
mediated Hz formation was concentration dependent and occurred rapidly with up to 75% of the total Hz being produced within the first
20 minutes. C, Native HDP (grey) can produce Hz at levels comparable to the recombinant protein (black). D, Powder X-ray diffraction pattern of
HDP-produced Hz matches with that of b-hematin. Inset–Scanning electron microscopy image of HDP-produced Hz crystallites that are 0.1–0.2 mmi n
length (arrows) with a width of approx.0.05 mm (Bar, 0.1 mm) E, Hz formation activity of 0.5 mM P. yoelii HDP (grey bars) is indistinguishable from its P.
falciparum ortholog, utilized at identical concentration (black bars). F, Full length HDP (closed circle) is necessary for Hz formation as HDP2 (open
circle) and HDP3 (closed triangle) alone could not produce Hz. 0.5 mM of each of the three proteins was utilized for analysis. G, Heme in 2 mM
increments was added to a 10 mM solution of either HDP, HDP2, HDP3 or polyhistidine peptide in 100 mM Sodium acetate buffer pH 5.2. Change in
absorbance at 414 nm was plotted against the concentration of heme. The curve depicts the non-linear fit of the data. H, HDP-mediated Hz
production is restricted to a pH range found inside the FV. I, CQ inhibits HDP-mediated Hz production. Values are mean6s. d
doi:10.1371/journal.ppat.1000053.g001
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domain alone is incapable of synthesizing Hz and an intact protein
is required for this activity (Fig. 1F). As part of the purification
strategy, HDP and its truncated versions also encode a hexa-
histidine tag (His6-tag). The Hz activity found in the full-length
HDP could not be attributed to the presence of the polyhistidine
tag as both HDP2 and HDP3 also encoded the tag but were
unable to produce Hz and a recombinantly produced P. falciparum
circumsporozoite protein containing a polyhistidine tag at its
carboxyl terminus did not produce Hz. Interaction of full-length
HDP with heme produced a Soret peak at 414 nm, whose
intensity increased with an increase in concentration of heme in
the reaction (Fig. 1G). In contrast, HDP2 and HDP3 showed 60–
75% decrease in their capacity to bind heme, in comparison to the
full-length protein (Fig.1G). Thus, the absence of Hz production
activity by the two truncated versions was due to a substantial
decrease in their potential to interact with heme. Heme-binding
activity of HDP was not associated with His6-tag, as the tag alone
showed negligible binding (to heme). Thus, a full-length HDP is
required for heme binding and Hz production activities of the
protein.
HDP-mediated Hz production requires acidic condition
In vivo, Hz formation occurs in an acidic (pH 4.5–5.2) milieu
[26] of the FV. Therefore, we investigated the optimal pH
requirement for the activity of HDP. We found that HDP
produced Hz at pH 5.2 or lower (Fig. 1H), showing complete loss
of activity with an increase in pH.
Effect of chloroquine on HDP-mediated Hz production
We subsequently tested the effect of chloroquine (CQ), a known
antimalarial drug that acts by binding to heme [7,8], on HDP-
mediated Hz production. We found that the reaction was inhibited
with an IC50 of 11 mM (Fig.1I). However, this inhibition was due
to the interaction of CQ with heme, as the drug had no
measurable interaction with HDP (data not shown).
HDP is thermostable in nature
Parasite extracts are known to retain their Hz production
activities even after boiling [13]. To evaluate if HDP could be
contributing towards this phenomenon, we incubated HDP at
94uC for 10 minutes and subsequently evaluated its propensity to
produce Hz. The protein produced Hz, with no measurable
decrease in activity with respect to control that was incubated at
room temperature for 10 minutes (Fig. 2A); thus suggesting that
HDP could have been the thermostable moiety present in the
extracts. Structural analysis of the heat-treated protein by circular
dichroic spectroscopy showed a spectrum that was qualitatively
similar to the untreated protein, thus suggesting an inherent
thermostability within the HDP structure (Fig. 2B).
HDP is the most potent Hz producer in Plasmodium
parasites
In vitro, histidine rich proteins [10] of P. falciparum and neutral
lipids [12,17,18] can produce Hz. We compared the potency of
HDP with the Hz production activities of Histidine Rich Protein-2
(HRP2), Monopalmitic glycerol (MPG), Mono-oleoyl glycerol
(MOG) and Oleic acid (OA). We varied the concentrations of
these mediators while keeping the substrate (heme) constant at
300 mM, giving rise to molar ratios widely utilized in previous
studies [10,12]. Hz production increased, in a concentration
dependent manner, with an increase in concentration of HDP,
MPG and MOG in the reaction (Fig. 2C). HDP-mediated
production rose rapidly, producing 71 mM of Hz at the highest
concentration of protein (0.6 mM) tested. In contrast, at the highest
concentration of MPG and MOG (300 mM) tested, which was
equal to the concentration of heme in the reaction, 17 and 30 mM
of Hz was produced, respectively. In comparison, only 0.1–
0.2 mM of HDP (Fig. 2C) was required to produce the same
amount of Hz. Thus, HDP was 1500–2000 folds more efficient
than MPG and MOG in converting heme into Hz. At their
highest concentration, HRP2 and OA could only produce a
maximum of 8 and 4 mM of Hz, respectively (Fig. 2C). Negligible
amounts (,0.1 mM) of Hz was produced in the absence of any of
these mediators.
Intracellular Localization of HDP reveals a circuitous
trafficking mechanism
As Hz formation occurs inside the FV, to be functionally
relevant, HDP should be present inside this organelle. Though the
Figure 2. Structural and biochemical analysis of HDP-mediated Hz formation. A, HDP (Black bars) retained its Hz production activity after
heat treatment (Hashed Bars) at 94uC for 10 minutes. B, CD spectra of heat-treated HDP is qualitatively similar to non-treated HDP, which was
incubated at room temperature. Mean residue ellipticity is expressed as degree cm
21 dmol
21. C, When compared to MPG (square), MOG (inverted
triangle), HRP 2 (diamond) and OA (triangle), HDP (circle) was most effective in producing Hz.
doi:10.1371/journal.ppat.1000053.g002
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targeting signal [27,28] that could predict its possible sorting and
transport to its destined site, we detected the presence of HDP, in
close proximity of Hz, within the FV (Fig. 3E), where it co-
localized with Plasmepsin II, a protease present in the food vacuole
(Fig. S3C–E). Therefore, to comprehend its trafficking, we
analyzed its expression through intraerythrocytic stages of
development in P. falciparum parasites. We discovered that from
the early (ring) stages of infection, HDP is secreted to the host cell
cytosol, before any detectable amount of Hz was visible inside the
parasite (Fig. 3A). The protein accumulated inside the infected
RBC cytosol (Fig. 3B,F) and was not exported out of the infected
RBC, as it could not be detected in the concentrated culture
supernatant by immunoblot (data not shown). Subsequently, as
parasite development progressed, we found that HDP (Fig. 3B),
along with host hemoglobin, is trafficked to the FV, via the
cytostome-mediated pathway (Fig. 3F). We detected the uptake of
HDP through the cytostome (Fig. 3B,G), its presence in the
transport vesicles (Fig. 3C,H) and subsequent delivery to the FV
(Fig. 3D), where large amounts of this protein could be found in
close proximity of the Hz crystal (Fig. 3E and Fig. S3D,F). The
recognition of HDP by the antibodies was specific, as .95% of the
immuno-gold reactivity was lost when antibodies were pre-
incubated with the recombinant protein (Fig. S4) and they also
did not recognize un-infected RBCs (data not shown). The
trafficking of HDP to the cytosol of the infected RBC did not occur
through a classical secretory pathway as it could not be blocked
when early ring stage parasites were treated with Brefeldin A (Fig.
S5).
This novel and circuitous trafficking route has never been
observed for any of the known Plasmodium proteins. Hence, to
validate this routing, we developed genetically modified parasite
Figure 3. Circuitous transport and delivery of HDP to the FV. A, HDP is secreted into the cytosol of infected erythrocytes (arrowhead) in early
ring stages before any Hz could be detected inside the parasite. B, After secreting it into the host cell cytosol, parasite intakes HDP through the
cytostome. C, HDP could be found in transport vesicles destined to the FV. D, Transport vesicles deliver HDP to the FV. E, HDP (arrows) was found in
close proximity of Hz crystals. F, HDP (18 nm particles) is transported to FV along with hemoglobin (12 nm particles). Inset G, HDP is being
internalized along with hemoglobin. Inset H, Transport vesicle ready to deliver both, HDP and hemoglobin, to the FV. cyt, cytostome; fv, food
vacuole; fvm, fv membrane; hz, hemozoin; hdp, heme detoxification protein; hb, hemoglobin; nu, nucleus; par, parasite; ppm, parasite plasma
membrane; pvm, parasitophorous vacuole membrane; irbc, infected red blood cell; rbcm, RBC membrane; tv, transport vesicle. Bar, 0.5 mm.
doi:10.1371/journal.ppat.1000053.g003
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(Fig. 4). Optimal trafficking requires recognition of specific motifs
in the target protein [27] and can be affected if a tag is present in
close proximity of the targeting signal [29]. As HDP does not
encode any of the known targeting signals identified in Plasmodium
[27,28], the optimal site for the attachment of c-Myc tag could not
be predicted. Therefore, we developed both, amino (c-MycHDP)
and carboxyl (HDPc-Myc) termini fusions for investigating its
trafficking (Fig. 4H). Upon expression, we found that both, c-
MycHDP (Fig. 4A) and HDPc-Myc (Fig. 4D), were secreted into
the cytosol of infected RBC. This not only validated our previous
observation that HDP is exported into the infected RBC cytosol
but also suggested that the protein encodes a hitherto unidentified
targeting signal, which facilitates its export to the host cell cytosol.
HDP does not undergo any proteolytic processing during its
export as the c-Myc tag, attached to either end of the protein, was
found to be intact (Fig. 4I). Like native HDP, the ‘‘inbound
trafficking’’ of the two tagged fusions could be seen via their
cytostomal uptake (Fig. 4A,D) and vesicular transport (Fig. 4B,E)
that led to the delivery of fusion proteins to the FV, where they
could be found in close proximity of Hz (Fig. 4C,F). The
recognition of the two tagged fusions (by anti c-Myc monoclonal
antibodies) was specific as wild-type 3D7 parasites showed no
immunogold staining (Fig. 4G). Thus, c-Myc based fusions
corroborated that HDP has an unusual trafficking route that has
never been observed for any of the known Plasmodium proteins
(schematic model depicted in Fig. S6).
Measurement of the amount of HDP produced by the
parasite
Western blot analysis of the trophozoite-infected RBC extract
revealed that HDP was present predominantly as a dimer, while
the FV preparation showed both the monomeric and dimeric form
of the protein (Fig. S7A). The presence of HDP in the FV was not
due to a contaminating cytosolic fraction, as the preparation was
negative for lactate dehydrogenase, a cytosolic enzyme (Fig. S7G).
Due to a continuous influx of HDP to the FV (Fig. 3E,F), its
concentration in this organelle cannot be accurately measured.
However, as the protein is first secreted into the RBC cytosol, by
using infected RBC extracts we measured total HDP produced by
the trophozoites by dot blot analysis (Fig. S7C–E) followed by a
densitometric quantitation (Fig. S7F) using ImageQuant software
(GE Biosciences). Intensity (in arbitrary units) of the spots
representing infected RBC extracts was plotted against the
intensity from the defined amounts of HDP. Albeit semi-
quantitative, it allowed us to estimate the relative amount of
HDP produced by the parasite. Though hemoglobin levels in an
infected RBC will not increase, our measurement, being a
snapshot of HDP levels that could be attained inside an infected
RBC, does not take into the account any subsequent production or
degradation of HDP that could have occurred during the
trophozoite stage of development. The analysis revealed that 1
million parasites express approximately 40 fmol of protein (Fig.
S7C–F). Therefore, each trophozoite could be producing up to 40
zeptomoles (zmol) of HDP. As an erythrocyte has a volume of 0.1
picoliter, concentration of HDP inside an infected RBC could
reach 0.4 mM.
HDP gene locus cannot be mutated
To determine if HDP is critical for parasite survival, we targeted
its locus in the P. falciparum genome. Our two attempts to disrupt
the HDP coding sequence did not produce parasite of the desired
phenotype (Fig. 5A). After three selection cycles under drug
pressure over a 4 month period, we could not detect site specific
recombinants and the plasmid was found to be maintained
episomally (Fig. 5B). Native HDP was also detectable using
immunofluorescence indicating that the HDP locus was not
disrupted (Fig. 5C). To demonstrate that this outcome is not due
to an error in the transfection process, we utilized a gene
replacement approach where we transfected P. falciparum parasites
with a plasmid encoding a promoter-less full length HDP in fusion
with the 25 kDa yellow fluorescent protein (YFP) (Fig. 6A). This
would allow us to detect the emergence of transfectants and follow
the trafficking of the chimeric protein [27]. While stable integrants
developed after three cycles of drug selection, as confirmed by
southern blot analysis, HDP locus was found to be intact, and
integration of HDP-YFP cassette had occurred elsewhere in the
genome (Fig. 6B). No YFP expressing parasites were visible using
live cell imaging with the native HDP still detectable by
immunofluorescence. This non-specific integration eliminated
the possibility of any error in the transfection process and
suggested that either the locus is recalcitrant to recombination or
the protein chimera produced after a successful recombination
event is non-functional and the resulting loss of HDP activity is
detrimental for the parasite. We explored this possibility by
episomally expressing HDP-YFP protein chimera in the parasite
(Fig. 7A). We found that, unlike the c-Myc based fusions, the
protein chimera accumulated within the parasite as the YFP-
associated fluorescence was not detected in the cytosol of infected
erythrocytes (Fig. 7B). This abrogation was due to YFP as its fusion
at the amino terminus of HDP (YFP-HDP) also produced a similar
phenotype, with fusion protein exclusively trapped within the
parasite (Fig. 7C,D). YFP, when expressed alone, also remained
within the parasite (Fig. 7E,F).
As both, c-Myc and YFP-based HDP fusions were expressed
using identical promoter and terminator sequences, an unimpaired
transport of the c-Myc tagged fusions, but, selective impairment of
YFP-based fusions, indicated that the attachment of a 238 amino
acids long YFP tag to a 205 amino acids HDP polypeptide has
obliterated the recognition of critical motif(s) required for its
export into the host cytosol. A similar phenomenon has been
reported for Plasmodium protein RIFIN, where attachment of a
GFP tag at its carboxyl terminus blocked its export into the
infected RBC cytosol [29]. Thus, it is conceivable that in our gene
replacement experiments, specific integration events led to the
expression of HDP-YFP fusion, which could not be exported to
the host cell cytosol and the resulting deprivation of the HDP-
associated activities negatively influenced the survival of these
genetically-modified parasites.
Figure 4. c-Myc tagged HDP has an identical trafficking pathway to HDP. Panels A–C depicts intracellular location of c-MycHDP fusion
protein in parasite-infected RBC. Cytostomal uptake of c-MycHDP (A) followed by its transport (B) and its presence within the FV (C) in close proximity
of Hz (shown by arrows). Panels D–F show intracellular location of HDPc-Myc, where, like HDP, chimera was present in the infected RBC cytosol (D),
detected in the process of being internalized (D), transported (E), and found in the FV (F), where it presence has been marked with arrows. G, c-Myc
antibodies specifically recognized the two chimeras as they did not recognize any protein in the non-transfected 3D7 P. falciparum parasites. H,
Schematic representation of the two c-Myc based fusion constructs utilized for expression. I, c-myc tag was still attached to HDP when the protein
was secreted out into the infected RBC cytosol. HDP was primarily present as a dimer, with little monomeric form also detected in c-MycHDP
preparation. cyt, cytostome; fv, food vacuole; hz, hemozoin; nu, nucleus; irbc, infected red blood cell; tv, transport vesicle. Bar, 0.5 mm
doi:10.1371/journal.ppat.1000053.g004
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Malaria gene PF14_0446 (HDP) was one of the several
hypothetical proteins selected for a malaria functional genomics
study, to understand their role in malaria pathogenesis. The
selection of these genes occurred through an in silico analysis,
where the Plasmodium genome was parsed using several bioinfor-
matical tools that predict the potential of a protein to be secreted
(SignalP [30], SecretomeP [31]), possession of transmembrane
domains and/or anchor sequences (TMHMM [32]), and the
presence of known membrane and/or extracellular domains
(SMART [33], CDD [34]). These analyses identified several
hundred proteins and the feasibility aspects of cloning and
expression led us to exclude sequences with low complexity
regions and extremely large size (.150 kDa), which are difficult to
express, purify and hence study. Specifically, for PF14_0446, it
Figure 5. Genetic manipulation of HDP locus. Schematic representation of the strategy used for targeting HDP locus through single cross over
recombination. A, Schematic representation of the plasmid and the genomic locus showing the enzyme sites and the genes flanking HDP. The
anticipated cross-over event at the HDP locus and restriction enzyme sites for Eco RV, E and Bam HI, B are shown. Eco RV site is unique to the parasite
DNA while Bam HI site is unique to the plasmid. B, Lanes 1 and 2, depict Bam HI-linearized pHDPKO (6.3 kb) and Eco RV and Bam HI digested DNA
from wild type P. falciparum parasites containing the HDP locus (5.3 kb), respectively. Lanes 3 and 4 depict the transfected parasites after 2
nd and 3
rd
drug cycle, respectively. Parasites surviving after three selection cycles (lanes 3, 4) had an intact HDP locus and an episomal copy of the pHDPKO
plasmid expressing hDHFR. The expected size on integration is indicated by the arrow (6657 bp). C, Immuno-fluorescence staining using anti-HDP
antibodies showed that the transfected parasites continually expressed HDP (green) even after the third drug cycle thus indicating that the locus was
not disrupted. Arrows on the DIC image indicate hemozoin. Parasite nucleus (blue) is stained with DAPI.
doi:10.1371/journal.ppat.1000053.g005
Heme Detoxification Protein Produces Hemozoin
PLoS Pathogens | www.plospathogens.org 8 April 2008 | Volume 4 | Issue 4 | e1000053predicted that the hypothetical protein lacks a classical signal
sequence and a transmembrane domain, but encodes fasciclin
domain and could be secreted through the non-classical pathway
of secretion. PF14_0446 (along with several other hypothetical
proteins) was cloned in an E. coli expression vector, expressed and
purified to homogeneity. The purified recombinant protein was
utilized for raising antibodies, which were subsequently used for the
immunolocalization studies performed on parasite-infected RBCs.
Our quest to understand the role of PF14_0446 began when we
found that on expression, PF14_0446 was present in two distinct
locations within the infected RBCs. This initial observation led us
to further analysis, where we found that not only the protein was
present in the cytosol of infected RBCs and in the FV, but it could
also be detected in transit vesicles, which are responsible for the
transport of host hemoglobin to the FV. Hence, we investigated
the possible role of this protein in the FV and soon found that it
had heme-binding properties (Fig. 1A). Though PF14_0446 has no
homology to any of the known heme binding proteins, however,
we found that it interacted and bound heme with high affinity (80
nM), with each polypeptide capable of binding 2.7 heme moieties.
This affinity is at least 4 times higher than HRP2, whose affinity
for heme is in 340–940 nM range [35]. A strong interaction of
PF14_0446 with heme led us to investigate if the protein could be
involved in Hz production. Using an established Hz formation
assay [10], we investigated this possibility and found that the
polypeptide showed robust Hz production. Hence, we named it as
Heme Detoxification Protein or HDP, a label which reflects
towards its putative function in the parasite.
We subsequently found that each molecule of recombinantly
produced protein could convert 1566 molecules of heme into Hz
hr
21, and the parasite-derived HDP had comparable activity. Our
estimation of HDP levels in trophozoite infected RBC revealed
Figure 6. Non-specific recombination of HDP-YFP chimera. A, Schematic representation of the gene replacement strategy employed for
obtaining HDP knocked-in parasites. The anticipated cross-over event at the HDP locus and the restriction enzyme sites for Eco RV, E and Xho I, X are
shown. B, Lanes 1 and 2 depict Xho I linearized pHDP-YFP (6.32 kb) and Xho I and Eco RV digested DNA from wild type P. falciparum parasites
containing the HDP locus (5.3kb), respectively. Lane 3 depicts the double digested DNA from transfected parasites after the 3
rd drug cycle. Integration
at non specific sites was observed as seen by higher size bands in comparison to the episomal plasmid, represented by the open arrows. As the
genomic DNA was digested with restriction enzymes unique to the flanking regions of the HDP locus (Eco RV) and the plasmid (Xho I) these bands do
not appear to be site specific integrations of concatameric forms of pHDP-YFP. No integration was observed at the expected size as indicated by the
arrow at 7588 bp. Parasites surviving after three selection cycles (lane 3) had the non-recombined HDP locus and no YFP expression, as determined by
fluorescence microscopy. C, Immuno-fluorescence staining of these parasites with anti HDP antibodies also indicated the expression of the native
HDP (green) after the third drug cycle. Arrows on the DIC image indicate hemozoin. Parasite nucleus (blue) is stained with DAPI.
doi:10.1371/journal.ppat.1000053.g006
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cytosolic ingredient, 75% of the host hemoglobin is endocytosed
and transported to the FV. A similar percentage of HDP, being
uniformly distributed in this milieu (Fig. 3F), will presumably be
transported to the FV, making 30 zmol of the protein available for
Hz production. Since a mature trophozoite contains 0.55–0.6 fmol
of heme as Hz [36]; with the conversion rate of 1566 molecules/
hour (Fig. 1B), we believe that HDP could indeed be a playing an
important role in Hz production in the parasite.
Though this rate does suggest the inherent potential of HDP in
making Hz in vivo; however, the exact percentage of its
contribution cannot be determined, because of an incomplete
knowledge of the in vivo hemoglobin processing steps, especially
the extent of proteolysis required for the release of heme (substrate)
from its globin moiety, which remains unknown. Emerging
evidences from several studies on parasite proteases involved in
hemoglobin degradation suggests that parasite utilizes ‘‘just in
time’’ concept to maintain its inventory of components required to
undertake a systematic degradation of host hemoglobin and Hz
formation [37,38]. For example–delivery of parasite protease
plasmepsin II to the food vacuole occurs along with the delivery of
hemoglobin [38] and HDP, as we have shown in this study.
Similarly, degradation of the inner membrane of the transit vesicle
is believed to be contributing towards the pool of lipid that are
subsequently found to be encapsulating the Hz. Mounting
evidence from the genetic manipulation studies involving malaria
proteases suggest towards redundancy, which generates an added
layer of complexity for deciphering the rate at which heme could
be released during hemoglobin proteolysis [39,40]. A constant
influx of the ‘‘hemoglobin processing tools’’ along with the
substrate (hemoglobin) thus suggests that at the minimum, the rate
of Hz production in the parasite is dependent on the rates at
which–(i) hemoglobin and its processors are imported into the FV
(ii) proteolysis of hemoglobin that leads to the release of heme (iii)
influx of HDP and lipids occurs in the FV (iv) HDP and lipids act
upon released heme and (v) their half life in the FV. Nonetheless, a
potent in vitro Hz activity, adequate production levels, its
indispensability from the parasite genome and an insight into its
transport and delivery to the FV does suggest that in vivo, HDP
could be an important contributor in achieving Hz levels found in
the parasite.
Parasite factors responsible for Hz production have been a subject
of intense debate. Slater and Cerami suggested the presence of a
heme polymerase in the malaria parasite [41] and a subsequent
demonstration of Hz production by HRP2 and HRP3 from P.
falciparum parasites lead to the possibility of these proteins being the
driving force behind Hz production [10]. However, (i) lack of HRP2
and HRP3 in other Plasmodium species, (ii) survival of P. falciparum
parasites in their absence [42] and (iii) the secretion of most of the
HRP2intothehostcirculation[43],diminished theirpotentialasthe
major producer of Hz in Plasmodium parasites. In contrast, we found
HDP to be present in all the species of Plasmodium (sequenced to
date), functionally conserved, and its locus being recalcitrant to
recombination, suggesting that it could be critical for the survival of
the parasite. We also found that an intact HDP was required for Hz
production, indicating that the fasciclin domain encoded in the
protein alone cannot produce Hz. As HDP encodes 2.7 heme
binding sites and its truncated versions (HDP2 and HDP3) retained
heme binding activities, albeit at much reduced levels, it suggested
that heme binding involves both the regions of HDP and only an
intact protein can facilitate Hz production. Interestingly, we also
identified HDP homologs in Babesia, Theileria and Toxoplasma
genomes; however, due to low sequence identity with members of
Plasmodium genus, they should not be presumed as Hz producers. As
HDPisalsoexpressedatotherstagesofthelifecycle,itispossiblethat
theproteincouldhaveotherfunctionsthatmightbeincommonwith
its homologs in Babesia, Theileria and Toxoplasma parasites.
In the parasite, a mixture of saturated and unsaturated fatty
acids and neutral lipids can be found inside the food vacuole [17].
Within the food vacuole, Hz crystal is encapsulated within neutral
lipids primarily composed of a mixture of mono- and diacyl
glycerols [17]. In vitro, neutral lipids MPG and MOG are some of
the most potent producers of Hz [12,17] and were therefore
utilized for comparison with the activity of HDP. Although
Figure 7. Episomal expression of the YFP-based chimera. P. falciparum 3D7 parasites were independently transfected with plasmids pHDP-YFP
(A), pYFP-HDP (C) and pYFP (E) containing the hDHFR cassette as selection marker. Culture was maintained in the presence of WR92210 and the
expression of yellow fluorescent protein was investigated by live cell imaging. On expression, transport of both the fusion proteins was found to be
disrupted (B and D) with protein exclusively localized within the parasite cytosol. pYFP, when expressed alone (F) showed YFP, like GFP [50], to be
localized within the parasite.
doi:10.1371/journal.ppat.1000053.g007
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utilizing lipids, invariably, as reported by Fitch [12], Sullivan [17]
and Egan [18] and shown here, these mediators are required at
concentrations that are either similar [12], equal [12,17] or in
excess [18] of heme. However, only 0.15 molecules of lipid have
been found to be associated with each molecule of heme [17]. We
also found neutral lipids to be efficient in converting heme into Hz,
albeit only when present at equimolar concentrations. In contrast,
1500–2000 fold lower concentrations of HDP could produce
comparable amounts of Hz, thus suggesting that on a molar basis
HDP is the most potent Hz producer in the parasite. The
difference in Hz activity between lipid and HDP couldn’t possibly
be due to unfavorable reaction conditions for lipids as under
similar conditions, Pisciotta et al found lipids to capable of rapidly
producing Hz crystals [17].
The presence of 2.7 heme binding sites in the protein, a high
affinity for heme and the rapid rate of conversion suggests that in
vivo, HDP is involved in the formation of Hz dimer. Its involvement
couldn’tpossibly be limited to a simple nucleation step as an increase
in the concentration of either heme or HDP in the reaction leads to
an increase in Hz formation. It can be hypothesized that in vivo,
HDP rapidly mediates the formation of Hz dimers and possibly
chaperones and delivers them to the lipid nanospheres where
stacking of these dimers leads to the Hz crystal. This could
potentiallyinvolveaninteraction between HDP andlipids.Recently,
Egan has proposed the possibility of an involvement of a protein
chaperone in incorporating heme into the lipid bodies [44].
Furthermore, modeling studies also suggest that hydrogen bonding
of the protonated propionic acid groups required for the final
assembly of the Hz crystal is strongly favored in the hydrophobic
lipid environment [18]. In evidence, .98% of the heme content in
the lipid bodies was present as Hz crystals and the stoichiometry of
heme:lipid found in these nanospheres [17] when utilized in vitro,
produced very little Hz. Alternately, a synergistic interaction
between lipids and HDP could be responsible for in vivo Hz
production and remains to be investigated.
Along with a distinct biochemical activity, we found that HDP
has a unique trafficking route. Though the protein does not encode
any of the known host cell targeting signals [27,28], which could
facilitate its transport across the parasite plasma membrane (PM),
parasitophorous vacuole (PV) or the PV membrane (PVM), we
found that HDP was readily secreted into infected RBC cytosol
before any Hz could be detected in the parasite; thus suggesting the
presence of novel targeting signals being encoded in the parasite
genome. In malaria parasite, a continuous outbound trafficking to
the PM of host RBC is equally matched with a concomitant
inbound trafficking of the host hemoglobin. Subsequently, in a
clear demonstration of functional convergence, we found that as
parasite endocytosed hemoglobin through a cytostomal-mediated
pathway, HDP was also internalized and co-transported to the food
vacuole. Interestingly HRP2, which is also secreted into the cytosol
of infected RBC by the parasite, is not internalized by the
cytostome and a direct routing of HRP2 from the parasite
cytoplasm to the food vacuole has been proposed [45]. It is
possible that HDP encodes signal(s) that facilitate its uptake
through the cytostome. Though a mechanism, where a Plasmodium
protein is first exported into the host cell cytosol only to be
subsequently imported by the parasite machinery has never been
reported for any of the known malaria proteins, the parasite does
incorporates Plasmpesin II, a protease involved in hemoglobin
degradation, into its plasma membrane, which during hemoglobin
uptake becomes part of the cytostome and transit vesicle [38].
Thus, a cytostome-based routing seems to be the parasite’s
preferred mechanism for delivering contents to the food vacuole.
To ourknowledge,thisisthe first reportofa pan-Plasmodiumheme
detoxifying protein that is highly efficient in mediating the
conversion of heme into Hz. As HDP had no homology to any of
the known heme binding proteins, itwould not have been possible to
predict its role in hemozoin formation by a bioinformatic approach
alone. This study is a text book example of not only the presence of
non-predictable activities in a protein, but also shows that following
genome sequencing of pathogens, identification of novel therapeutic
targets will require experimental support by classical biochemical
and cellbiologicalapproaches.Identification ofHDPnotonlyfillsan
important gap in our understanding of the mechanism of Hz
production in malaria parasite, but the novel ‘‘Outbound-Inbound’’
trafficking of HDP also reveals an interesting insight into the inner
workings of the parasite. Transcriptomic [19] and proteomic [46]
studies of malaria parasite indicate that HDP is also expressed at
mosquito and liver stages of the lifecycle, suggesting that the protein
could have more than one function in the lifecycle of the parasite.
Identification of new drug targets is vital for developing the next
generation antimalarial drugs. With our discovery, drugs that
specifically interact with HDP and obliterate its detoxification
activities could potentially be developed.
Materials and Methods
Cloning, recombinant expression and purification of HDP
Coding sequence of HDP was amplified by RT-PCR using total
RNA from the P. falciparum (3D7 strain) erythrocytic stage
parasites. The amplified fragment was cloned in pET101, a V5
epitope and polyhistidine-tag encoding, T7 promoter-based E. coli
expression vector, giving rise to plasmid pHDP. Protein, expressed
in BL21 cells, was localized in inclusion bodies, which were
isolated as described previously [47]. Purified inclusion bodies
were solubilized in 50 mM CAPS buffer (pH 11.0) containing
1.5% N-lauryl sarkosine and 0.3 M NaCl, for 30 minutes and the
solubilized protein was separated by centrifugation (10,0006g;
30 minutes). Protein was purified by affinity chromatography on
His-Trap, a high performance nickel affinity column (GE Health
Care) using an imidazole gradient in 50 mM CAPS pH 11.0
containing 0.3% N-lauryl sarkosine and 0.3 M NaCl. Protein-
containing fractions were pooled and purified to homogeneity by gel
filtrationchromatographyonSuperdex20010/300GLcolumn(GE
Health Care), equilibrated in 25 mM CAPS (pH 11.0) containing
135 mM NaCl. PyHDP was amplified by RT-PCR using total
erythrocytic stage P. yoelii RNA and cloned in pET101 plasmid.
Plasmids encoding proteins HDP2 and HDP3 were generated by
sub-cloning using pHDP as template. Their expression and
purification was performed as described above. DNA encoding P.
falciparum HRP 2 was cloned in pET101 and its expression and
purification was performed as described previously [10].
Measurement of Binding affinity
Binding affinity of HDP for heme was evaluated by Isothermal
titration calorimetry where freshly prepared heme solution was
incrementally added to 5 mM HDP (in 50 mM MES, pH 5.6)
present inside the ITC cell. Data was collected at 30uCa ta
420 rpm stir rate using 10 ml injections of the 100 mM heme into
the protein solution. The resulting measurements, delta H vs.
molar ratio, were fit to a single binding site model using the
MicroCal Origin analysis software.
Hz formation assay
The assay was performed as previously described [10] with the
following parameters. Unless otherwise stated all hemozoin
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reaction volume with 0.5 mM HDP and 300 mM heme.
Time Kinetics. In a 1 ml reaction, recombinant HDP at a
final concentration of 0.5 mM was mixed with either 300 or
600 mM of freshly prepared heme solution. The reaction was
buffered with 500 mM sodium acetate pH 5.2 and was incubated
at 37uC for different time periods (1–720 minutes). The reaction
was stopped by adding SDS (0.1% final concentration).
Unsequestered heme was removed by repeated washing of the
pellet with 2.5% SDS and 0.1 M sodium bicarbonate (pH 9.1)
followed by distilled water till no soluble heme was visible in the
supernatant. Hz pellet was resuspended in 1 ml of 0.1 N NaOH
and absorbance was measured at 400 nm. A standard curve using
different concentrations of b-hematin was prepared to quantitate
the amount of heme incorporated into Hz. A reaction containing
buffered heme alone was used as negative control.
Native vs. Recombinant HDP. Purified native and recom-
binant HDP (0.05 mM each) in 500 mM sodium acetate buffer
pH 5.2 were incubated at 37uC with physiologically relevant
concentration of freshly prepared heme for 60 minutes and the
amount of Hz produced was measured as described above.
pH Optima. pH dependence of HDP was evaluated in
500 mM sodium acetate buffer of different pH (pH 3.2–6.0).
Effect of CQ. 0.5 mM HDP was incubated with 300 mM
heme in the absence (control) or presence of increasing
concentration of CQ (5–50 mM) for 1 hour. Amount of Hz
produced in reaction containing CQ was measured and compared
with control reactions that did not receive any drug. Data was
plotted as percentage inhibition with respect to control reactions.
Heat Treatment. Recombinant HDP (0.5 mM) was
incubated at 94uC for 10 minutes before being evaluated in a
1hr Hz assay as described above.
Comparative analysis of 4 Hz producers. Increasing
concentration of HDP (0.1–0.6 mM), MPG, MOG, OA (0.05–
300 mM) and HRP 2 (0.05–1.0 mM) were added in a 1 ml reaction
buffered with sodium acetate pH 5.2 and containing a fixed
concentration (300 mM) of freshly prepared heme. The reaction
was incubated at 37uC for 60 minutes followed by separation and
estimation of Hz as described above. All the Hz formation assays
were performed at least three times in triplicates.
HDP-Heme interaction
HDP heme interactions were measured spectrophotometrically
as described [10]. Hemin stock solution in 0.1N NaOH was added
simultaneously into two cuvettes, one containing a solution of
10 mM protein (HDP, HDP2 or HDP3) or polyhistidine tag in
0.1 M sodium acetate buffer, pH 5.2, and the other containing
only buffer (reference cuvette), in 2 mM increments. After each
addition of heme, the samples in the two cuvettes were mixed and
allowed to stand for 5 minutes. Difference in absorption spectra
(over 200–800 nm range) between the reference and experimental
cuvette was recorded using a spectrophotometer (GE Healthcare).
Heme binding curve was constructed by plotting the change in
absorbance at the Soret peak (414 nm) versus the heme
concentration using the non-linear regression function in Sigma
Plot Software (Systat Software Inc.).
Immunoelectron microscopy
P. falciparum infected erythrocytes were purified over a magnetic
column, fixed in 4% paraformaldehyde/0.1% glutaraldehyde in
100 mM PIPES/0.5 mM MgCl2, pH 7.2 for 1 hour at 4uC and
used for immunoelectron microscopy as described [38]. Controls
omitting the primary antibody were consistently negative at the
concentration of gold-conjugated secondary antibodies used in
these studies. Transfected parasites expressing c-Myc fusions were
probed using anti-cMyc monoclonal antibodies 9E10.
Targeted deletion of HDP
P.falciparum3D7 parasites was cultured in human O+erythrocytes
asdescribed previously.Todisrupt the HDP genomiclocus,a 509 bp
locus targeting sequence beginning at the first methionine of HDP
was PCR amplified using primers with in frame stop codons. This
fragment was cloned into pHD22Y using the Kpn I restriction enzyme
site to yield pHDPKO. The stop codons in the forward and reverse
primers would prevent expression of the truncated HDP in the event
of site specific recombination. Ring stage parasites at 10%
parasitemia were transfected by electroporation with 100 mgo f
super coiled pHDPKO using low voltage/high capacitanceconditions
[48]. In an attempt to replace the genomic HDP locus with a HDP-
YFP gene chimera, theplasmid pHDP-YFPwasconstructed using the
pPM2GT plasmid as a backbone [38]. PM2 was replaced with a
targeting sequence comprising the entire promoter-less HDP gene
using the unique Xho Ia n dAvr II restriction enzyme sites.
Subsequently, the GFP was replaced with YFP and a spacer peptide
was maintained in frame between HDP and YFP,a si nt h eo r i g i n a l
pPM2GT plasmid [38]. The promoter less nature of this chimera
allowed detection of site specific integrants as only integrants at the
HDP locus would express YFP. The pHDP-YFP plasmid was
transfected into ring stage parasites as described above. All
transfectants were selected in the presence of 10 nM WR99210 (a
gift from Dr. Jacobus, Jacobus Pharmaceuticals, Princeton NJ) and
subjected to three drug selection cycles, each consisting of 21 days of
growth in absence of WR99210 followed by reselection of parasites
in the presence of 10 nM WR99210. The genotypes of parasites
resulting from the pHDPKO and the pHDP-YFP transfections were
analyzed by probing blots of Eco RV-Bam HI and Eco RV-Xho I
digested total parasite DNA, respectively with a PCR amplified 509
bp fragment of HDP that has been cloned in the transfection vector.
The signal was generated with an Alk Phos direct labeling and
detection kit as per manufacturer’s instruction (GE Healthcare).
Episomal expression of c-Myc and YFP-based chimeric
protein
The vector for the transient expression of chimeric proteins was
designed based on a well documented episomal segregation system
reported in P falciparum parasites [49]. The segregation sequence,
Rep 20, was amplified from P falciparum genomic DNA and cloned
into the Spe I site of the pBluescript SK (+) vector to yield the plasmid
P1. The HDP-YFP fusion was amplified from pHDP-YFP using
primers with Cla I and Eco RI sites and subcloned into the above
plasmid yielding P2. Sequence representing Plasmodium berghei dhfr
39UTR was amplified from P. berghei strain ANKA using primers
with Eco RI and Pst 1 sites and subcloned into the P2 plasmid to
yield the plasmid P3. The 59UTR of Plasmodium chaubaudi dhfr gene
was amplified from pGFPREP2 (gift from Michael Klemba) using
primers with Xho I and Cla I sites and subcloned into the plasmid
P3 to yield plasmid P4. The drug resistance marker hDHFR was
amplified from the pHHT-TK vector and subcloned into the P4
plasmid using the Kpn I and Xho I site to create the final vector
pHDPYFP. Site directed mutagenesis was utilized to insert a Nhe I
site between the HDP and YFP sequence in pHDPYFP such that
the HDP sequence was flanked by Cla I and Avr II while the YFP
sequence was flanked by the Nhe I and Eco RI restriction enzyme
sites, respectively, to yield the C terminal fusion expression vector
pHDPYFP-NheI. To generate the N terminal fusion, pYFPHDP, the
HDP sequence was amplified using a forward primer with Nhe I site
and reverse primer with Eco RI site. This PCR product was sub-
cloned into the modified base vector pHDPYFP-Nhe I yielding
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utilized for the second step of subcloning. YFP was amplified using
a forward primer with the Cla I site and the reverse primer with
the Avr II site. This product was then sub-cloned as a Cla I-Avr II
fragment to yield pYFPHDP.
For generating the control pYFP expressing vector, the YFP
sequence was PCR amplified using a forward primer with a Cla I
site and the reverse primer with the Eco RI site. This product was
sub-cloned into the Cla I-Eco RI site of pHDPYFP-Nhe I to yield the
pYFP control plasmid. Primers used for all subcloning steps were
designed such that all the sequences were maintained in frame
thus allowing expression of the YFP alone and, the C and N
terminus YFP tagged proteins.
For generating plasmids with c-myc epitope tagged at the N or
C terminus of HDP, pHDPYFP vector was utilized as the base
vector. For the N terminus fusion, the HDP gene was PCR
amplified using a primer containing the Cla I site with an in frame
c-myc sequence, and a reverse primer containing the Eco RI site.
This product was then digested and sub-cloned into the Cla I-Eco
RI site of pHDPYFP to yield the pc-MycHDP. Similarly for the C
terminus tagged HDP, the forward primer specific to HDP
containing the Cla I site and the reverse primer with the in-frame
c-myc sequence with a 59 Eco RI site were used for PCR
amplification of HDP and sub-cloned into the Cla I-Eco RI site of
the base vector to yield pHDPc-Myc plasmid. All the plasmids were
sequenced before each subcloning step to verify the constructs.
Transfections were carried out with ring stage parasites as
described above and drug resistant parasites were selected using
10 nM WR99210. All the transfection experiments were
performed at least two times using 2 independent clones of each
plasmid. Western blots of transfected parasites were performed
using monoclonal antibody against the c-myc tag.
Protocol S1 describes methods employed for X-Ray diffraction,
Scanning Electron Microscopy, CD spectroscopy, Preparation of
parasite extract, Purification of native HDP, Isolation of food
vacuole and Estimation of HDP.
Supporting Information
Protocol S1 Describes methods employed for X-Ray diffraction,
Scanning Electron Microscopy, CD spectroscopy, Preparation of
parasite extract, Purification of native HDP, Isolation of food
vacuole and Estimation of HDP.
Found at: doi:10.1371/journal.ppat.1000053.s001 (0.09 MB
DOC)
Figure S1 Cloning, expression and purification of HDP
proteins. A, RT-PCR amplification of HDP coding sequence. B,
Schematic representation of HDP gene structure, HDP protein
and its two truncated variants, HDP 2 and HDP 3. C,
Recombinantly expressed and purified HDP proteins on a 12%
Coomassie stained gel under reducing conditions. D, Immunoblot
of purified proteins with anti-HDP antibodies.
Found at: doi:10.1371/journal.ppat.1000053.s002 (3.04 MB TIF)
FigureS2 Multiple sequence alignment of HDP protein sequence.
Sequences were aligned using the Clustal W algorithm. Amino acids
in bold represent residues that are conserved across all the known
homologs of PfHDP. Residues marked with an asterisk represent
amino acid positions that are identical only in the Plasmodium genus.
Overall, the Plasmodium sequences have 60% amino acid identity.
Fasciclin 1 domain of PfHDP has been aligned with the consensus
sequence of Fasciclin 1 domain and has an e-value of 3e-10.
Found at: doi:10.1371/journal.ppat.1000053.s003 (4.74 MB TIF)
Figure S3 Co-localization of HDP and Plasmepsin II antibodies.
Images A–F Represent a cross section of 0.20 mm thickness
obtained by deconvolution microscopy. A, Differential Interfer-
ence Contrast (DIC) image of a purified food vacuole with a visible
Hz crystal. Arrows indicate the food vacuole membrane. B, FV
preparation was free from nuclear contaminants as no staining
with DAPI was observed. C, Localization of plasmepsin II. D,
HDP was present within the food vacuole. E, HDP and
Plasmepsin II show co-localization (yellow regions marked with
white arrows) within the FV. F, Merged image of DIC and
Fluorescence showing the presence of HDP and PMII around
hemozoin. Bars represent 1 mm, with the average size of the FV
determined to be 2.0–2.3 mm in diameter.
Found at: doi:10.1371/journal.ppat.1000053.s004 (0.56 MB TIF)
Figure S4 Specificity of anti-HDP antibodies. Immunoelectron
microscopy, performed as mentioned in the methods section,
demonstrated the specificity of anti-HDP antibodies. A, Preincu-
bation of anti-HDP antibodies with recombinant HDP resulted in
a .95% loss of recognition of HDP in the parasite. B, Recognition
of parasite-produced HDP was not affected when serum albumin
was used as a non-specific ligand for anti-HDP antibodies. Scale is
500 nm.
Found at: doi:10.1371/journal.ppat.1000053.s005 (1.13 MB TIF)
Figure S5 Brefeldin A treatment of parasites. PfHDP transport
to the host RBC cytoplasm is not perturbed by Brefeldin A
treatment. The top panel is a representative of 16 hour BFA
treated parasite. Similar pattern of HDP expression is consistent in
all the parasites visualized and in all BFA treatment conditions.
Panel A–F Represents a cross section of a parasite with A,
Representing DIC; B, Nuclear staining; C, HDP staining and D,
The overlaid images. Early stage control 3D7 parasites E–H
Representing DIC, nuclear and HDP staining, respectively.
Found at: doi:10.1371/journal.ppat.1000053.s006 (4.78 MB TIF)
Figure S6 Schematic model describing the Outbound-Inbound
trafficking of HDP. A, During the intraerythrocytic stages of
development, HDP mRNA is translated on the ribosomes and the
polypeptide is exported to the cytosol of infected RBC. Owing to
the lack of any known signal sequence and host targeting signals,
its trafficking within the parasite cytosol and transport across the
parasite plasma membrane (PM), parasitophorous vacuole (PV)
and PV membrane (PVM) occurs through a hitherto unknown
mechanism. B, As hemoglobin uptake is initiated, HDP along with
host hemoglobin is endocytosed by the parasite and is transported
in transit vesicles to the food vacuole, where it is involved in Hz
production. Nu: Nucleus; Fv: Food vacuole; iRBC, infected red
blood cell.
Found at: doi:10.1371/journal.ppat.1000053.s007 (8.52 MB TIF)
Figure S7 Estimation of HDP levels in extracts of trophozoite
stage infected RBCs (iRBC). A, Immunoblot, using anti-HDP
antibodies, on protein extracts from 30.5 million iRBCs and 11.6
million FV, detected intact HDP according to its predicted size in
both, dimeric and monomeric forms. Lanes 1 and 2 represent 5
and 0.5 ng of recombinant HDP, respectively; lane 3 represents
total protein of trophozoite-infected RBCs; lane 4 shows protein
derived from food vacuoles; and lane 5 represents iRBC cytosol. A
higher molecular weight band detected in the protein extracts
derived from food vacuole (lane 4) could correspond to HDP that
is either associated with heme/Hz or with other macromolecules
present within the food vacuole. Arrow indicates the monomeric
form of protein. Absence of food vacuole associated monomeric
and higher molecular weight HDP bands in trophozoite-infected
RBC (lane 3) could be due to incomplete lysis of the cells during
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PLoS Pathogens | www.plospathogens.org 13 April 2008 | Volume 4 | Issue 4 | e1000053the freeze thaw process. B, Native HDP from the iRBC extract
was purified by immunoprecipitation for Hz assay. Left panel-
silver stained gel, right panel-Immunoblot. Molecular weight
standards are represented in kDa. Absence of monomeric form of
HDP in these preparations is associated with a stringent washing
of immunoprecipitated protein-bead complex. Protein prepara-
tions produced under less-stringent conditions contained both the
monomeric and dimeric form of the protein along with other
contaminants. However, this heterogeneous preparation was also
capable of producing Hz (data not shown). C, Dot blot with
different concentrations of purified recombinant HDP. D, Defined
number of iRBC and E, Uninfected RBCs probed with anti-HDP
antibodies. F, Estimation of HDP in iRBC. Intensity (arbitrary
units) of spots on dot blot of different concentrations of
recombinant HDP (circle) on upper X-axis analysis, compared
with the intensity of defined number of iRBC (triangle) on lower
X-axis. It is estimated that 1 million parasite produce 40 fmol of
HDP. G, Determination of purity of food vacuoles by Lactate
Dehydrogenase assay. Extracts of food vacuoles and purified
trophozoite infected RBCs corresponding to 9.7610
6 infected cells
were assayed for lactate dehydrogenase activity. Error bars
indicate standard deviation.
Found at: doi:10.1371/journal.ppat.1000053.s008 (6.75 MB TIF)
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